Arteriosclerosis Thrombosis and Vascular Biology (ATVB)
Publisher :
Wolters Kluwer Medknow
Medicine
Cardiology
Cardiovascular Medicine
e-ISSN :
1524-4636
Issue Frequency :
Monthly
Impact Factor :
8.7
p-ISSN :
1079-5642
Est. Year :
1995
Mobile :
8002428721
Country :
United States
Language:
English
APC :
YES
Email :
atvb@atvb.org
Journal Descriptions
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) publishes laboratory-based, translational, clinical and population research that is related to cardiovascular, peripheral vascular and cerebrovascular biology and disease. Areas of focus include atherosclerosis, lipid biology, arterial stiffening, thrombosis and hemostasis, and vascular and valvular biology. ATVB encourages submissions that use state-of-the-art approaches to illuminate mechanisms of disease and uncover new therapies and biomarkers through experimentation in animal and cellular models and in humans. The journal values novel technological developments—such as in bioengineering and with ‘omics platforms.
ATVB maintains the highest standards of methodological and statistical rigor, prioritizes engagement with the research community (readers, authors, AHA/ATVB members, and our Early Career Editorial Board mentees) and publishes original research as well as scientific statements, viewpoints, opinions and consortium papers. Through dissemination of the highest quality research, ATVB supports the overall mission of the American Heart Association: to promote longer and healthier lives.
Arteriosclerosis Thrombosis and Vascular Biology (ATVB)
is :
International, Peer-Reviewed, Open Access, Refereed,
Medicine, Cardiology, Cardiovascular Medicine
,
Online
or
Print,
Monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 1079-5642, E-ISSN - 1524-4636, Established in - 1995, Impact Factor - 8.7
True scholar network
